Antibody acquisition after second and third SARS-CoV-2 vaccinations in Japanese kidney transplant patients: a prospective study.

Hidetaka DeguchiAtsuhiko SakamotoNobuyuki NakamuraYasuhiro OkabeYoshifumi MiuraTakeshi IidaMichinobu YoshimuraNobuhiro HagaShigeki NabeshimaKosuke Masutani

Published in: Clinical and experimental nephrology (2023)

In Japanese kidney transplant patients, years after kidney transplant, ABO-incompatible kidney transplant and mycophenolate mofetil use were predictors for antibody acquisition after second vaccination. Third vaccination improves antibody status even in patients who were seronegative after the second vaccination.

Keyphrases

end stage renal disease
sars cov
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
coronavirus disease
respiratory syndrome coronavirus